Open an account

Virtus Biotech ETF

BBP · ETF

$102.07−$1.89 (−1.82%)TodayMarket closed ·
Prev close $103.96

About BBP

BBP was created on 2014-12-17 by Virtus. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 129.42m in AUM and 66 holdings. BBP tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider.

Issuer
Virtus
Tracks
LifeSci Biotechnology Products Index
Expense ratio
0.34%
Assets under management
$131.11M
Inception
Dec 17, 2014
Asset class
Equity
Website
virtus.com

BBP key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
15.31K
Volume
9.84K
Open price
$103.19
High today
$102.55
Low today
$101.54
52 Week high
$110.05
52 Week low
$71.65

Virtus Biotech ETF (BBP) at a glance

As of Oct 23, 2026, Virtus Biotech ETF (BBP) shares are priced at $102.07, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $101.54 and $102.55. The current price is 0.5% above the day's low and 0.5% below its high.

Volume so far is 9.84K shares, below the average of 15.31K shares a day.

Over the past year Virtus Biotech ETF has ranged from $71.65 to $110.05, and now sits 79% of the way up that range.

BBP news

  • Vandana Singh

    ImmunityBio Stock Climbs As FDA Accepts Expanded Use Filing For Bladder Cancer Drug

  • Vandana Singh

    ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check

  • Vandana Singh

    ImmunityBio Stock Jumps As New Bladder Cancer Guideline Boosts Anktiva Use

  • Vandana Singh

    Why Is ImmunityBio Stock Soaring On Friday?

  • Vandana Singh

    ImmunityBio Announces FDA Resubmission For Expanded Use Of Lead Drug

  • Vandana Singh

    Why Is ImmunityBio Stock Gaining Tuesday?

  • Lekha Gupta

    Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion

  • Michael Juliano

    FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.